MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/neuonc/noag266

Медицинская библиотека · Neuro-oncology · 2026

EGFRvIII-Positive Glioblastoma: Structural Rewiring, Immune Microenvironmental Remodeling, and Therapeutic Resistance.

Ye Haoyuan, Qiu Jinming, Zhu Fangge, Quan Rong, Su Wenting, Wang Renxi, Fu Yi

СтатьяПеревод пока не подготовлен

Аннотация

Glioblastoma (GBM) harboring EGFRvIII represents a biologically distinct and highly aggressive tumor subset characterized by aberrant receptor signaling, marked intratumoral heterogeneity, and profound immune remodeling. Rather than acting as a constitutively active truncated receptor, EGFRvIII represents a structurally rewired EGFR variant whose altered extracellular architecture, receptor assembly, and trafficking promote ligand-independent signaling and signaling plasticity, thereby supporting tumor proliferation, stemness, invasion, and angiogenesis. Beyond tumor-intrinsic effects, EGFRvIII also contributes to the formation of a spatially heterogeneous, myeloid-dominant and immunosuppressive tumor microenvironment, characterized by myeloid-cell expansion, impaired T cell effector function, and mesenchymal-like tumor-immune plasticity. Despite extensive therapeutic efforts including tyrosine kinase inhibitors, monoclonal antibodies, vaccines, immune checkpoint blockade, and EGFRvIII-targeted CAR-T cell strategies, durable clinical efficacy remains limited by the interplay of antigen heterogeneity, adaptive signaling, clonal evolution, and microenvironmental immunosuppression. Taken together, EGFRvIII can be viewed as a structural and evolutionary regulator that links receptor rewiring and signaling plasticity with immune ecosystem remodeling and therapeutic resistance, underscoring the need for integrated strategies that target both tumor cell-intrinsic signaling and the suppressive microenvironment.

Для цитирования: Ye Haoyuan, Qiu Jinming, Zhu Fangge, Quan Rong, Su Wenting, Wang Renxi, Fu Yi. EGFRvIII-Positive Glioblastoma: Structural Rewiring, Immune Microenvironmental Remodeling, and Therapeutic Resistance.. Neuro-oncology. 2026. DOI: 10.1093/neuonc/noag266.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.